PMC · DOI:10.3389/fimmu.2026.1779800·January 15, 2026
Correction: Perspective: IL-15 cytokine-armored NK cells as ready-to-use immunotherapy for diverse malignancies: therapeutic potential and toxicity risks
Scott L. Baughan, Timothy Folsom, Matt Johnson, Joshua Kreuger, Beau R. Webber, Branden S. Moriarity
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsImmune Cell Function and Interaction · CAR-T cell therapy research · IL-33, ST2, and ILC Pathways